Please find enclosed herewith Outcome of Board Meeting dated 08th May, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Accretion Nutraveda Ltd reported strong FY 2025-26 audited results with revenue growing 110% to Rs 3,360.31 Lakhs from Rs 1,600.18 Lakhs. PAT surged 103% to Rs 506.83 Lakhs from Rs 250.09 Lakhs, with EPS of Rs 9.35 vs Rs 6.88. The company received an unmodified (clean) audit opinion from VSSB & Associates. The board saw significant changes: two independent directors (Arun Dash and Mahipal Singh Chouhan) resigned citing personal/professional commitments, while two new independent directors (Chand Rameshbhai Kanabar and Ms. Grishma A Shewale) were appointed. New secretarial auditors (Sakhiya & Co.) and internal auditors (UMT & Co.) were appointed. The company also listed on BSE SME in February 2026 via IPO raising Rs 2,476.80 Lakhs, with Rs 1,821.32 Lakhs utilized so far.
The company delivered exceptional revenue and profit growth following its recent IPO listing. However, negative operating cash flow of Rs 2,278.43 Lakhs despite high profitability warrants attention. The simultaneous resignation of two independent directors may raise governance concerns despite clean auditor opinion.